Fractyl Health announced new data supporting its Revita procedure and priced a new public offering.
The data came from the company’s Germany Real-world Registry. It showed that a single Revita procedure led to durable weight...
Fractyl Health announced new data supporting its Revita procedure and priced a new public offering.
The data came from the company’s Germany Real-world Registry. It...
Cornerstone Robotics and researchers at the Chinese University of Hong Kong (CUHK) say they made a breakthrough in surgical robotics.
According to a news release,...
Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.
The deal equates to the buyout...
Pulsecare Medical announced that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology.
Shenzhen, China–based Pulsecare develops the NxPFA nanosecond PFA system....
Fractyl Health announced new data supporting its Revita procedure and priced a new public offering.
The data came from the company’s Germany Real-world Registry. It...
The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents.
The...
Xvivo announced it enrolled the first patient as part of a continued access protocol (CAP) study for its Heart Assist Transport system.
The CAP study...
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...
Fractyl Health announced new data supporting its Revita procedure and priced a new public offering.
The data came from the company’s Germany Real-world Registry. It...
Cornerstone Robotics and researchers at the Chinese University of Hong Kong (CUHK) say they made a breakthrough in surgical robotics.
According to a news release,...
Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.
The deal equates to the buyout...
Pulsecare Medical announced that Chinese regulatory authorities granted marketing approval for its pulsed field ablation technology.
Shenzhen, China–based Pulsecare develops the NxPFA nanosecond PFA system....